BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 123710
Published online Aug 15, 2026. doi: 10.4251/wjgo.123710
Table 1 Clinicopathological data of hepatocellular carcinoma patients (n = 102)
Clinicopathological index
Number of patients
%
SexMale5452.94
Female4847.06
Age (years)< 606765.69
> 603534.31
Hepatitis B/C surface antigenPositive6866.67
Negative3433.33
Liver cirrhosisYes7977.45
No2322.55
Liver function classificationChild-Pugh A7472.55
Child-Pugh B2827.45
Tumor size (cm)> 54140.20
< 56159.80
Tumor numberSingle8482.35
Multiple1817.65
AFP level (ng/mL)> 4006462.75
< 4003837.25
Vascular invasionYes3938.24
No6361.76
Cancer embolismYes3837.25
No6462.75
Pathological gradeI/II5957.84
III/IV4342.16
TNM stagingI6159.80
II/III4140.20
Table 2 Relationship between tensin 4 protein expression and clinicopathological features in hepatocellular carcinoma, n (%)
Clinicopathological feature
n
Negative expression
Positive expression
P value
SexMale5412 (22.22) 42 (77.78) 0.569
Female4813 (27.08) 35 (72.92)
Age (years)< 606717 (25.37) 50 (74.63) 0.779
> 60358 (21.05) 27 (78.95)
Hepatitis B/C surface antigenPositive6819 (27.94) 49 (72.06) 0.255
Negative346 (17.65) 28 (82.35)
Liver cirrhosisYes7918 (22.78) 61 (77.22) 0.453
No237 (30.43) 16 (69.57)
Liver function classificationChild-Pugh A7415 (20.27) 59 (79.73) 0.106
Child-Pugh B2810 (35.71) 18 (64.29)
Tumor size, cm> 54111 (26.83) 30 (73.17) 0.655
< 56114 (22.95) 47 (77.05)
Tumor numberSingle8418 (21.43) 66 (78.57) 0.118
Multiple187 (38.89) 11 (61.11)
AFP level (ng/mL)> 4006413 (20.31) 51 (79.69) 0.201
< 4003812 (31.58) 26 (68.42)
Vascular invasionYes395 (12.82) 34 (87.18) 0.031
No6320 (31.75) 43 (68.25)
Cancer embolismYes385 (13.16) 33 (86.84) 0.04
No6420 (31.25) 44 (68.75)
Pathological gradeI/II5919 (32.20) 40 (67.80) 0.034
III/IV436 (13.95) 37 (86.05)
TNM stagingI6117 (27.87) 44 (72.13) 0.336
II/III418 (19.51) 33 (80.49)


Write to the Help Desk